Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03813199
Recruitment Status : Recruiting
First Posted : January 23, 2019
Last Update Posted : July 15, 2019
Sponsor:
Information provided by (Responsible Party):
Abivax S.A.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2020
  Estimated Study Completion Date : September 2020